These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 23208041)

  • 1. [Development of an efficient short interference RNA (siRNA) delivery system with a new pH-sensitive cationic lipid].
    Sato Y; Hatakeyama H; Hyodo M; Akita H; Harashima H
    Yakugaku Zasshi; 2012; 132(12):1355-63. PubMed ID: 23208041
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A pH-sensitive cationic lipid facilitates the delivery of liposomal siRNA and gene silencing activity in vitro and in vivo.
    Sato Y; Hatakeyama H; Sakurai Y; Hyodo M; Akita H; Harashima H
    J Control Release; 2012 Nov; 163(3):267-76. PubMed ID: 23000694
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Size-dependent specific targeting and efficient gene silencing in peritoneal macrophages using a pH-sensitive cationic liposomal siRNA carrier.
    Matsui H; Sato Y; Hatakeyama H; Akita H; Harashima H
    Int J Pharm; 2015 Nov; 495(1):171-178. PubMed ID: 26355712
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A pH-sensitive fusogenic peptide facilitates endosomal escape and greatly enhances the gene silencing of siRNA-containing nanoparticles in vitro and in vivo.
    Hatakeyama H; Ito E; Akita H; Oishi M; Nagasaki Y; Futaki S; Harashima H
    J Control Release; 2009 Oct; 139(2):127-32. PubMed ID: 19540888
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Multifunctional Envelope-Type Nano Device Containing a pH-Sensitive Cationic Lipid for Efficient Delivery of Short Interfering RNA to Hepatocytes In Vivo.
    Sato Y; Harashima H; Kohara M
    Methods Mol Biol; 2016; 1364():71-8. PubMed ID: 26472443
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene silencing via RNAi and siRNA quantification in tumor tissue using MEND, a liposomal siRNA delivery system.
    Sakurai Y; Hatakeyama H; Sato Y; Hyodo M; Akita H; Harashima H
    Mol Ther; 2013 Jun; 21(6):1195-203. PubMed ID: 23568259
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RNAi-mediated gene knockdown and anti-angiogenic therapy of RCCs using a cyclic RGD-modified liposomal-siRNA system.
    Sakurai Y; Hatakeyama H; Sato Y; Hyodo M; Akita H; Ohga N; Hida K; Harashima H
    J Control Release; 2014 Jan; 173():110-8. PubMed ID: 24120854
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficient short interference RNA delivery to tumor cells using a combination of octaarginine, GALA and tumor-specific, cleavable polyethylene glycol system.
    Sakurai Y; Hatakeyama H; Akita H; Oishi M; Nagasaki Y; Futaki S; Harashima H
    Biol Pharm Bull; 2009 May; 32(5):928-32. PubMed ID: 19420766
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The systemic administration of an anti-miRNA oligonucleotide encapsulated pH-sensitive liposome results in reduced level of hepatic microRNA-122 in mice.
    Hatakeyama H; Murata M; Sato Y; Takahashi M; Minakawa N; Matsuda A; Harashima H
    J Control Release; 2014 Jan; 173():43-50. PubMed ID: 24511611
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systemic delivery of siRNA to tumors using a lipid nanoparticle containing a tumor-specific cleavable PEG-lipid.
    Hatakeyama H; Akita H; Ito E; Hayashi Y; Oishi M; Nagasaki Y; Danev R; Nagayama K; Kaji N; Kikuchi H; Baba Y; Harashima H
    Biomaterials; 2011 Jun; 32(18):4306-16. PubMed ID: 21429576
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reducing the Cytotoxicity of Lipid Nanoparticles Associated with a Fusogenic Cationic Lipid in a Natural Killer Cell Line by Introducing a Polycation-Based siRNA Core.
    Nakamura T; Yamada K; Fujiwara Y; Sato Y; Harashima H
    Mol Pharm; 2018 Jun; 15(6):2142-2150. PubMed ID: 29668291
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficient Packaging of Plasmid DNA Using a pH Sensitive Cationic Lipid for Delivery to Hepatocytes.
    Sakurai Y; Matsuda T; Hada T; Harashima H
    Biol Pharm Bull; 2015; 38(8):1185-91. PubMed ID: 26235581
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional improvement of an IRQ-PEG-MEND for delivering genes to the lung.
    Ishitsuka T; Akita H; Harashima H
    J Control Release; 2011 Aug; 154(1):77-83. PubMed ID: 21619903
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ornithine and tryptophan analogs as efficient polycations for short interference RNA delivery to tumor cells.
    Sato Y; Hatakeyama H; Harashima H
    Biol Pharm Bull; 2010; 33(7):1246-9. PubMed ID: 20606322
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endosomal escape and the knockdown efficiency of liposomal-siRNA by the fusogenic peptide shGALA.
    Sakurai Y; Hatakeyama H; Sato Y; Akita H; Takayama K; Kobayashi S; Futaki S; Harashima H
    Biomaterials; 2011 Aug; 32(24):5733-42. PubMed ID: 21605898
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systemic delivery of therapeutic small interfering RNA using a pH-triggered amphiphilic poly-L-lysine nanocarrier to suppress prostate cancer growth in mice.
    Guo J; Cheng WP; Gu J; Ding C; Qu X; Yang Z; O'Driscoll C
    Eur J Pharm Sci; 2012 Apr; 45(5):521-32. PubMed ID: 22186295
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Development of a Novel Liposomal DDS by Manipulating Pharmacokinetics and Intracellular Trafficking for Drug Therapy and Nucleic Acid Medicine].
    Hatakeyama H
    Yakugaku Zasshi; 2018; 138(5):591-598. PubMed ID: 29709998
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Understanding structure-activity relationships of pH-sensitive cationic lipids facilitates the rational identification of promising lipid nanoparticles for delivering siRNAs in vivo.
    Sato Y; Hashiba K; Sasaki K; Maeki M; Tokeshi M; Harashima H
    J Control Release; 2019 Feb; 295():140-152. PubMed ID: 30610950
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multifunctional pH-Sensitive Amino Lipids for siRNA Delivery.
    Gujrati M; Vaidya A; Lu ZR
    Bioconjug Chem; 2016 Jan; 27(1):19-35. PubMed ID: 26629982
    [TBL] [Abstract][Full Text] [Related]  

  • 20. pH-labile PEGylation of siRNA-loaded lipid nanoparticle improves active targeting and gene silencing activity in hepatocytes.
    Hashiba K; Sato Y; Harashima H
    J Control Release; 2017 Sep; 262():239-246. PubMed ID: 28774839
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.